You are here: Industry Insights > nasal

News List

LENI Flap Reliable for Nasal Defect Reconstruction europeanpharmaceuticalreview
July 10, 2019
LENI Flap Reliable for Nasal Defect Reconstruction.
FDA Approves First Drug for Sinusitis With Nasal Polyps, Dupixent (Dupilumab) drugs
June 28, 2019
FDA Approves First Drug for Sinusitis With Nasal Polyps, Dupixent (Dupilumab).
Dupixent Approved for Chronic Rhinosinusitis With Nasal Polyps drugs
June 27, 2019
Dupixent Approved for Chronic Rhinosinusitis With Nasal Polyps.
Whitepaper: VIVAPUR® MCG – a powerful stabiliser for nasal sprays europeanpharmaceuticalreview
June 17, 2019
JRS Pharma present VIVAPUR MCG and outline the benefits of its formulation for application in nasal sprays.
Naloxone Available in One in Three Philadelphia Pharmacies drugs
June 10, 2019
Naloxone Available in One in Three Philadelphia Pharmacies.
Health Tip: Nasal Spray Safety drugs
June 06, 2019
For people who use nasal sprays to combat seasonal allergies, it's important to follow safety guidelines, says the Allergy & Asthma Network.
Esketamine Nasal Spray May Improve Refractory Depression Outcomes drugs
June 03, 2019
Esketamine Nasal Spray May Improve Refractory Depression Outcomes.
FDA Approves Nayzilam (midazolam) Nasal Spray to Treat Seizure Clusters drugs
May 21, 2019
FDA Approves Nayzilam (midazolam) Nasal Spray to Treat Seizure Clusters.
Recipharm Launches Inhalation Offering contractpharma
May 16, 2019
Offers fully integrated service from early stage development through to commercial manufacturing for MDIs, DPIs, and nasal sprays.
Aptar Pharma’s Bidose Nasal Drug Delivery Device Approved by U.S. FDA for Breakthrough Treatment of Depression pharmafocusasia
March 20, 2019
Aptar Pharma, a leading drug delivery systems provider, is pleased to announce that its Bidose nasal spray device was recently approved by the U.S. FDA for a breakthrough therapy in the field of depression. This marks the first FDA approval and U.S. launc

Previous page 1 2 Next page